Chimin Health Management Co Ltd operates in the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chimin Health Management Co Ltd with three other
companies in this sector in China:
Guanhao Biotech Co Ltd
(2018
sales of 458.46 million Chinese Renmimbi [US$65.19 million]
of which 96%
was Medical apparatus and instruments),
Ningbo David Medical Device Co Ltd
(300.30 million Chinese Renmimbi [US$42.70 million]
of which 51%
was Incubator Series), and
Jiangsu Nanfang Medical Co Ltd
(479.82 million Chinese Renmimbi [US$68.23 million]
of which 50%
was Band Aid).
Sales Analysis.
Chimin Health Management Co Ltd reported sales of 697.83 million Chinese Renmimbi (US$99.22 million)
for the
year ending
December of 2018.
This
represents
an
increase of 15.7%
versus 2017, when the company's sales were 602.90 million Chinese Renmimbi.
This was the third consecutive year of growth at Chimin Health Management Co Ltd.
Sales of Medical Service Industry saw an increase
that was more than double the company's growth rate: sales were up
92.2% in 2018, from
105.16 million Chinese Renmimbi to 202.09 million Chinese Renmimbi.
Not all segments of Chimin Health Management Co Ltd experienced an increase in sales in 2018:
sales of Pharmaceutical Trade Industry fell 10.9% to 20.16 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).